TY - JOUR
T1 - Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses
AU - Lawler, Nathan G.
AU - Gray, Nicola
AU - Kimhofer, Torben
AU - Boughton, Berin
AU - Gay, Melvin
AU - Yang, Rongchang
AU - Morillon, Aude Claire
AU - Chin, Sung Tong
AU - Ryan, Monique
AU - Begum, Sofina
AU - Bong, Sze How
AU - Coudert, Jerome D.
AU - Edgar, Dale
AU - Raby, Edward
AU - Pettersson, Sven
AU - Richards, Toby
AU - Holmes, Elaine
AU - Nicholson, Jeremy K.
PY - 2021/5/7
Y1 - 2021/5/7
N2 - We performed quantitative metabolic phenotyping of blood plasma in parallel with cytokine/chemokine analysis from participants who were either SARS-CoV-2 (+) (n = 10) or SARS-CoV-2 (-) (n = 49). SARS-CoV-2 positivity was associated with a unique metabolic phenotype and demonstrated a complex systemic response to infection, including severe perturbations in amino acid and kynurenine metabolic pathways. Nine metabolites were elevated in plasma and strongly associated with infection (quinolinic acid, glutamic acid, nicotinic acid, aspartic acid, neopterin, kynurenine, phenylalanine, 3-hydroxykynurenine, and taurine; p < 0.05), while four metabolites were lower in infection (tryptophan, histidine, indole-3-acetic acid, and citrulline; p < 0.05). This signature supports a systemic metabolic phenoconversion following infection, indicating possible neurotoxicity and neurological disruption (elevations of 3-hydroxykynurenine and quinolinic acid) and liver dysfunction (reduction in Fischer's ratio and elevation of taurine). Finally, we report correlations between the key metabolite changes observed in the disease with concentrations of proinflammatory cytokines and chemokines showing strong immunometabolic disorder in response to SARS-CoV-2 infection.
AB - We performed quantitative metabolic phenotyping of blood plasma in parallel with cytokine/chemokine analysis from participants who were either SARS-CoV-2 (+) (n = 10) or SARS-CoV-2 (-) (n = 49). SARS-CoV-2 positivity was associated with a unique metabolic phenotype and demonstrated a complex systemic response to infection, including severe perturbations in amino acid and kynurenine metabolic pathways. Nine metabolites were elevated in plasma and strongly associated with infection (quinolinic acid, glutamic acid, nicotinic acid, aspartic acid, neopterin, kynurenine, phenylalanine, 3-hydroxykynurenine, and taurine; p < 0.05), while four metabolites were lower in infection (tryptophan, histidine, indole-3-acetic acid, and citrulline; p < 0.05). This signature supports a systemic metabolic phenoconversion following infection, indicating possible neurotoxicity and neurological disruption (elevations of 3-hydroxykynurenine and quinolinic acid) and liver dysfunction (reduction in Fischer's ratio and elevation of taurine). Finally, we report correlations between the key metabolite changes observed in the disease with concentrations of proinflammatory cytokines and chemokines showing strong immunometabolic disorder in response to SARS-CoV-2 infection.
KW - biogenic amines
KW - COVID-19
KW - cytokines
KW - host response
KW - kynurenine
KW - metabolic phenotyping
KW - phenoconversion
KW - SARS-CoV-2
KW - tryptophan
UR - http://www.scopus.com/inward/record.url?scp=85103773984&partnerID=8YFLogxK
U2 - 10.1021/acs.jproteome.1c00052
DO - 10.1021/acs.jproteome.1c00052
M3 - Article
C2 - 33724837
AN - SCOPUS:85103773984
SN - 1535-3893
VL - 20
SP - 2796
EP - 2811
JO - Journal of Proteome Research
JF - Journal of Proteome Research
IS - 5
ER -